ArticleNature communications2023

Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

R C Coombes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.